Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Quercus Alba Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of White Oak-induced allergic rhinitis and asthma. It belongs to the class of Non-Standardized Pollen Allergenic Extracts [EPC].
Name
Quercus Alba Pollen
Raw Name
QUERCUS ALBA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
21
Variant Count
23
Last Verified
February 17, 2026
About Quercus Alba Pollen
Quercus Alba Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of White Oak-induced allergic rhinitis and asthma. It belongs to the class of Non-Standardized Pollen Allergenic Extracts [EPC].
Detailed information about Quercus Alba Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Quercus Alba Pollen.
Quercus Alba Pollen, commonly known as White Oak Pollen, is a biological substance used primarily in the field of allergy and immunology. It belongs to a pharmacological class known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are complex mixtures of proteins, glycoproteins, and polysaccharides derived from the pollen of the Quercus alba tree, which is native to North America. In clinical practice, this extract serves a dual purpose: it is utilized as a diagnostic tool to identify patients with specific IgE-mediated hypersensitivity and as a therapeutic agent in allergen immunotherapy (AIT), often referred to as 'allergy shots.'
According to the FDA-approved labeling, these extracts are indicated for patients whose history reveals a significant sensitivity to White Oak pollen and whose symptoms are not adequately controlled by environmental avoidance or pharmacotherapy (such as antihistamines or nasal corticosteroids). The Quercus genus is a major contributor to vernal (springtime) pollinosis, and Quercus alba is one of the most clinically significant species due to its high pollen production and widespread distribution. Because this is a 'non-standardized' extract, its potency is typically measured in Protein Nitrogen Units (PNU) or weight-to-volume (w/v) ratios, rather than bioequivalent allergy units (BAU).
The mechanism of action for Quercus Alba Pollen depends on its clinical application. In diagnostic skin testing, the extract is introduced into the epidermis (the outermost layer of skin). If the patient has pre-existing IgE antibodies specific to White Oak proteins, these antibodies—which are bound to the surface of mast cells—will cross-link upon contact with the allergen. This triggers the degranulation (release) of inflammatory mediators, primarily histamine. This results in a localized 'wheal and flare' reaction (a raised bump and surrounding redness), which is the hallmark of a positive skin test.
In therapeutic immunotherapy, the mechanism is far more complex and involves a fundamental 're-training' of the immune system. When administered subcutaneously (under the skin) in gradually increasing doses, the extract induces a shift in the immune response from a Th2-dominated profile (which promotes allergy and IgE production) to a Th1-dominated or T-regulatory (Treg) profile. This process leads to the production of 'blocking antibodies,' specifically IgG4. These IgG4 antibodies compete with IgE for allergen binding, effectively preventing the allergic cascade before it begins. Furthermore, long-term immunotherapy reduces the recruitment of eosinophils and basophils to the shock organs (the nose, eyes, and lungs), leading to a sustained reduction in clinical symptoms.
As a biological allergenic extract, the pharmacokinetic profile of Quercus Alba Pollen does not follow the traditional ADME (Absorption, Distribution, Metabolism, and Excretion) patterns of small-molecule drugs.
Quercus Alba Pollen extracts are FDA-approved for the following indications:
Quercus Alba Pollen is primarily available in the following forms:
> Important: Only your healthcare provider can determine if Quercus Alba Pollen is right for your specific condition. The complexity of allergen selection and the risk of severe reactions require management by a board-certified allergist or immunologist.
Dosage for Quercus Alba Pollen is highly individualized and is never a 'one-size-fits-all' regimen. It is divided into two distinct phases: the Build-up Phase and the Maintenance Phase.
During this phase, patients typically receive injections once or twice weekly. The starting dose is usually extremely dilute (e.g., 0.05 mL of a 1:100,000 w/v or 10 PNU/mL dilution). The dose is increased incrementally (often by 25% to 50% each time) until the 'Maintenance Dose' is reached. This process generally takes 3 to 6 months depending on the patient's sensitivity and adherence.
Once the target dose is reached (the dose that provides maximum symptom relief with minimal side effects), the frequency of injections is decreased. Maintenance injections are typically given every 2 to 4 weeks. A common maintenance volume is 0.5 mL of a 1:10 or 1:20 w/v concentration, though this varies significantly based on the specific extract manufacturer and patient tolerance.
Quercus Alba Pollen is generally considered safe and effective for pediatric use in children who are old enough to cooperate with the injection and monitoring process (usually age 5 and older). The dosing logic for children is identical to that of adults—starting with a very low dose and titrating upward based on tolerance. However, healthcare providers may use more cautious increments in highly sensitive children to minimize the risk of systemic reactions.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared by the kidneys. However, the patient's overall health and ability to survive a potential anaphylactic event must be considered.
No dosage adjustments are necessary for hepatic impairment. The metabolism of allergenic proteins occurs via cellular proteolysis, not hepatic enzyme systems.
Elderly patients require careful assessment. While there is no specific age-based dose reduction, the presence of comorbid conditions (like cardiovascular disease) may make the use of immunotherapy riskier. If an elderly patient is on beta-blockers, immunotherapy is often avoided (see Interactions).
Quercus Alba Pollen extract must ONLY be administered by a healthcare professional in a clinical setting equipped to handle anaphylaxis.
If a dose is missed during the build-up phase, the next dose may need to be reduced depending on how much time has elapsed.
An 'overdose' in the context of immunotherapy usually refers to an accidental administration of a higher-than-intended concentration or volume.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-administer these injections without medical guidance.
Most patients undergoing immunotherapy with Quercus Alba Pollen will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Quercus Alba Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects of Quercus Alba Pollen when administered correctly. The primary long-term effect is the desired 'immunological tolerance,' where the body no longer reacts to oak pollen. However, some studies have investigated the theoretical risk of developing autoimmune conditions due to chronic immune stimulation, but current clinical data from the American Academy of Allergy, Asthma & Immunology (AAAAI) does not show a significant increase in such risks for the general population.
Quercus Alba Pollen extracts carry an FDA-mandated warning regarding the risk of severe, life-threatening systemic reactions.
Report any unusual symptoms to your healthcare provider. Even a 'large' local reaction (larger than a half-dollar) should be reported, as it may predict a future systemic reaction.
Quercus Alba Pollen is a potent biological agent. Its safety depends entirely on correct administration and patient selection. It is not a 'cure' for allergies but a long-term management strategy that carries inherent risks. Patients must be committed to the schedule and the safety protocols established by their allergist.
"Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis and death. They should be administered only by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients should be observed for at least 30 minutes after an injection. Patients with unstable asthma or those taking beta-blockers are at increased risk."
The most significant risk is a systemic allergic reaction. This risk increases if the patient is currently experiencing high levels of natural pollen exposure (e.g., during peak oak season), if they are ill with a virus, or if they have recently exercised vigorously (which increases blood flow and allergen absorption).
Quercus Alba Pollen itself does not cause sedation. However, if a patient experiences a systemic reaction or is given antihistamines/epinephrine to treat a reaction, their ability to drive or operate machinery will be significantly impaired. It is generally advised to wait until any post-injection lightheadedness has completely resolved.
While there is no direct chemical interaction between alcohol and Quercus Alba Pollen, alcohol consumption can cause vasodilation (widening of blood vessels). This may theoretically increase the rate of allergen absorption from the injection site, potentially increasing the risk of a systemic reaction. It is best to avoid alcohol for several hours before and after an injection.
Immunotherapy can be stopped at any time, but doing so will result in a gradual return of allergy symptoms. There is no 'withdrawal syndrome.' However, if a patient stops for several months and wishes to restart, they cannot resume at their previous dose; they must start over at the beginning of the build-up phase to ensure safety.
> Important: Discuss all your medical conditions with your healthcare provider before starting Quercus Alba Pollen. Ensure they are aware of any history of heart disease, severe asthma, or previous severe reactions to insect stings or foods.
There are no known direct food interactions with Quercus Alba Pollen. However, patients with 'Oral Allergy Syndrome' (OAS) may find that eating certain fruits (like apples or peaches) during oak season increases their overall 'allergic load,' potentially making them more sensitive to their injections.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter nasal sprays can be relevant to your treatment plan.
Patients allergic to Quercus Alba (White Oak) are almost always cross-sensitive to other members of the Quercus genus, such as Red Oak (Quercus rubra) or Live Oak (Quercus virginiana). They may also show sensitivity to other trees in the Fagaceae family, including Beech and Chestnut trees. This is due to the presence of highly conserved (similar) proteins across these species.
> Important: Your healthcare provider will evaluate your complete medical history, including any underlying heart or lung conditions, before prescribing Quercus Alba Pollen.
It is not known whether the allergenic components of Quercus Alba Pollen are excreted in human milk. However, because these are large proteins that are processed locally in the mother's immune system, it is highly unlikely that they would reach the infant in any significant amount via breast milk. Immunotherapy is generally considered safe for breastfeeding mothers.
Quercus Alba Pollen is commonly used in children.
In patients over age 65, the decision to use Quercus Alba Pollen must be made with caution.
There are no specific studies on Quercus Alba Pollen in patients with kidney disease. However, since the extract is not cleared renally, no dose adjustments are typically required. The primary concern would be the patient's overall physiological resilience in the event of a systemic reaction.
Liver disease does not affect the processing of allergenic extracts. No dosage adjustments are needed for patients with hepatic impairment. As with renal patients, the focus remains on the patient's ability to tolerate potential emergency treatments.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health conditions during the course of your treatment.
Quercus Alba Pollen extract works by inducing immunological tolerance. At the molecular level, the primary allergen in White Oak (often identified as Que a 1, a pathogenesis-related protein) is captured by Dendritic Cells (DCs). These DCs present the allergen to 'naive' T-cells. In an allergic individual, this presentation normally leads to the creation of Th2 cells.
Immunotherapy changes this by promoting the development of Regulatory T-cells (Tregs). These Tregs secrete IL-10 and TGF-beta, which signal B-cells to stop producing IgE and start producing IgG4. This IgG4 acts as a 'decoy,' binding to the oak pollen proteins before they can reach the IgE on mast cells, thus preventing the release of histamine and leukotrienes.
| Parameter | Value |
|---|---|
| Bioavailability | Low (intended for local immune processing) |
| Protein Binding | N/A (Biological protein) |
| Half-life | N/A (Degraded by proteases within hours/days) |
| Tmax | 30-60 minutes (for systemic absorption) |
| Metabolism | Cellular Proteolysis |
| Excretion | Cellular turnover |
Quercus Alba Pollen is classified as a Non-Standardized Pollen Allergenic Extract [EPC]. It is part of a broader group of biologicals used for 'In Vivo Diagnostic Biologicals' and 'Allergen Immunotherapy.' It is distinct from 'Standardized' extracts (like Grass or Ragweed) because it does not have a federally mandated bioassay to determine its exact 'Allergy Unit' potency.
Common questions about Quercus Alba Pollen
Quercus Alba Pollen extract is primarily used for the diagnosis and treatment of allergies to White Oak tree pollen. In diagnostic settings, it is used in skin prick tests to confirm if a patient's respiratory symptoms, such as sneezing or wheezing, are caused by an oak allergy. Therapeutically, it is used in 'allergy shots' (immunotherapy) to help the body build a tolerance to the pollen over time. This treatment is intended for patients who do not get enough relief from standard allergy medications. It is a long-term process that can significantly reduce the severity of hay fever and allergic asthma symptoms.
The most common side effects are local reactions at the site of the injection, including redness, itching, and a raised bump or 'wheal.' These reactions are usually mild and disappear within a few hours, though some can last for a day or two. Some patients may also experience a temporary increase in their typical allergy symptoms, like a runny nose or itchy eyes, shortly after the injection. Fatigue is another frequently reported side effect following an immunotherapy session. While these are common, any reaction that is larger than two inches in diameter should be reported to your doctor. Serious systemic reactions are rare but require immediate medical attention.
It is generally recommended to avoid alcohol on the days you receive a Quercus Alba Pollen injection. Alcohol can cause your blood vessels to dilate (widen), which might speed up the absorption of the allergen into your bloodstream and increase the risk of a systemic allergic reaction. Furthermore, alcohol can impair your ability to recognize the early warning signs of anaphylaxis. To ensure maximum safety, most allergists suggest waiting at least several hours after your injection before consuming any alcoholic beverages. Always discuss your lifestyle habits with your healthcare provider to ensure your treatment is as safe as possible.
Quercus Alba Pollen immunotherapy is typically not started during pregnancy because of the risk of a severe allergic reaction, which could deprive the developing fetus of oxygen. However, if a woman is already on a stable maintenance dose and becomes pregnant, many doctors allow the treatment to continue at that same dose. The decision depends on the mother's history of reactions and the severity of her allergy symptoms. It is vital to inform your allergist immediately if you become pregnant so they can adjust your treatment plan. No new increases in dosage should occur until after the baby is born.
Immunotherapy with Quercus Alba Pollen is a slow process and does not provide immediate relief like an antihistamine would. Most patients begin to notice a decrease in their allergy symptoms after 6 to 12 months of consistent treatment, usually once they have reached the maintenance phase. The full benefits are typically seen after the second or third year of injections. Because the treatment involves changing the way your immune system functions, patience and adherence to the schedule are essential. Most experts recommend continuing the treatment for 3 to 5 years to ensure the results last long after the injections are stopped.
Yes, you can stop taking Quercus Alba Pollen injections at any time without experiencing physical withdrawal symptoms. However, stopping the treatment before the recommended 3-to-5-year course is complete will likely result in your allergy symptoms eventually returning to their original severity. If you miss several doses and then decide to restart, you cannot simply pick up where you left off. Your doctor will need to significantly reduce the dose and slowly build it back up to ensure your safety. Always consult with your allergist before deciding to discontinue your immunotherapy program.
If you miss a dose of Quercus Alba Pollen, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. If you are only a week late, your doctor may give you your usual dose, but if several weeks have passed, they will likely need to reduce the amount of extract given to prevent a reaction. Safety is the priority, and the dosing schedule is carefully designed to keep your immune system from being overwhelmed. Regularity is key to the success of the treatment, so try to keep your appointments as consistent as possible.
There is no clinical evidence to suggest that Quercus Alba Pollen allergenic extracts cause weight gain. Unlike systemic corticosteroids (such as prednisone), which are known to affect metabolism and appetite, allergenic extracts are biological proteins that work specifically on the immune system. The amount of protein in each injection is microscopic and does not have metabolic effects on body weight. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking. You should discuss any concerns about weight with your primary care physician.
Quercus Alba Pollen can be taken with many common medications, but there are some critical exceptions. The most important interaction is with beta-blockers, which are often used for high blood pressure or heart conditions; these can make a severe allergic reaction much harder to treat. Other drugs, like ACE inhibitors or certain antidepressants (MAOIs), may also increase the risks associated with immunotherapy. Antihistamines won't stop the treatment from working, but they must be stopped before skin testing because they can cause false results. Always provide your allergist with a complete list of all medications and supplements you are using.
The concept of 'generic' vs. 'brand name' is a bit different for allergenic extracts like Quercus Alba Pollen. Because these are biological products derived from natural sources, they are produced by several different specialized laboratories (such as HollisterStier, Greer, or ALK). While they all contain the same essential White Oak pollen proteins, they are not considered 'interchangeable' in the same way a generic pill is. If your doctor switches you from one manufacturer's extract to another, they will often reduce your dose slightly to account for potential differences in potency between the two products. This ensures your safety during the transition.